Showing 1 - 20 results of 30,409 for search '(( six times decrease ) OR ((( a ((nn decrease) OR (a decrease)) ) OR ( a largest decrease ))))', query time: 0.54s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    A flow diagram of the study entry. by Sakiko Fukui (387048)

    Published 2025
    “…We created a time-series dataset for 69 participants, documenting their average weekly food intake (on a scale of 0-10). …”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  13. 13

    Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx by Le Zhang (88249)

    Published 2025
    “…<p>Global damming of rivers strongly impacts the transport and characteristic of sediment, resulting in a significant reduction in the suspended sediment content (SSC) flowing into the downstream. …”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Change in rectal temperature following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

    Published 2025
    “…<p>Dogs were studied in six groups in a cross over design combining premedications and warming devices: acepromazine and no warming devices (ACE-NONE; gray circles), acepromazine and conventional warming devices (ACE-CONV; gray triangles), acepromazine and the AVAcore (ACE-AVA, gray squares), dexmedetomidine and no warming devices (DEX-NONE, white circles), dexmedetomidine and conventional warming devices (DEX-CONV, white triangles), and dexmedetomidine and the AVAcore (DEX-AVA, white squares). …”
  20. 20